Results 181 to 190 of about 22,851 (227)
Some of the next articles are maybe not open access.
Thromboprophylaxis in Cancer Patients
Seminars in Thrombosis and Hemostasis, 2014Cancer-associated thrombosis (CAT) is frequent and associated with significant morbidity and mortality among cancer patients. Hospitalized medically ill cancer patients are considered to be at high risk of CAT complications. Parenteral thromboprophylaxis with low-molecular-weight heparin is likely to reduce the risk of venous thromboembolism in this ...
Marc, Carrier, Agnes Y Y, Lee
openaire +2 more sources
Thromboprophylaxis in Spinal Surgery
Spine, 2018Study Design. Systematic review and meta-analysis. Objective. Determine the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in spinal surgery patients receiving no thromboprophylaxis, mechanoprophylaxis, and chemoprophylaxis ...
William P, Mosenthal +6 more
openaire +2 more sources
Thromboprophylaxis in neurosurgical patients
Seminars in Hematology, 2000Neurosurgical patients constitute one of the highest risk groups for postoperative thromboembolic complications. Physical methods of thromboprophylaxis have been successful in reducing the incidence of postoperative deep vein thrombosis (DVT) but the residual incidence remains considerable.
openaire +2 more sources
British journal of hospital medicine, 1993
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source
Thromboprophylaxis in cancer surgery
2011The presence of cancer, overt or occult, is thrombogenic to the individual. This has been recognised from the time of Armand Trousseau who, in 1865 [1], stated: “I have long been struck with the frequency with which cancerous patients are affected with painful oedema of the superior or inferior extremities, whether or not either was the seat of the ...
David Gozzard, David Perry
openaire +1 more source
Thromboprophylaxis in a Pediatric Hospital
Current Problems in Pediatric and Adolescent Health Care, 2013Venous thromboembolism (VTE) in children is an emerging area of focus in pediatric hospitals in recent years. Although VTE in hospitalized children occurs much less often than in adults, there are a significant number of children at risk of VTE who may benefit from thromboprophylaxis.
Mukta, Sharma, Shannon L, Carpenter
openaire +2 more sources
Thromboprophylaxis and Neuraxial Anesthesia
Orthopedics, 2003Abstract Spinal hematoma is a rare and potentially catastrophic complication of spinal or epidural anesthesia. Risk factors include traumatic needle/catheter placement, sustained anticoagulation in an indwelling neuraxial catheter, and catheter removal during therapeutic levels of anticoagulation.
openaire +2 more sources
Thromboprophylaxis in Emergency Surgery
Haemostasis, 2009Except for hip fracture surgery, emergency surgery has been only exceptionally studied concerning thromboprophylaxis. There are, however, several reasons to believe the frequency to be fairly high and that the patient group would be in need of prophylaxis.
D, Bergqvist +7 more
openaire +2 more sources
Thromboprophylaxis in the Cancer Patient
Acta Haematologica, 2001Cancer patients not undergoing treatment and without a history of venous thrombosis do not, as a general rule, require prophylaxis. However, venous thromboembolism is of sufficient magnitude in patients undergoing treatment for cancer for thromboprophylaxis to be routinely employed.
P A, Thodiyil, D C, Walsh, A K, Kakkar
openaire +2 more sources
Thromboprophylaxis during chemotherapy: NO
Thrombosis Research, 2010There is a wide range in rates of thrombosis in patients on chemotherapy reported in the literature. This is likely as a result of study design and case selection. The interest in primary prevention of venous thromboembolism in patients on chemotherapy has been rekindled by the association between antiangiogenic agents and thrombosis.
openaire +2 more sources